CRDL Earnings Date: Nov 12, 2026 (Estimated) — Cardiol Therapeutics Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
Updated
When is CRDL's next earnings date?
Cardiol Therapeutics Inc. (CRDL) is expected to report Q3 2026 earnings on Thursday, November 12, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.06.
How did CRDL do in its last earnings report?
In its most recent report on Aug 13, 2026, Cardiol Therapeutics Inc. posted EPS of -$0.04 versus the -$0.09 estimate, a beat of 55.6%. The stock's 1-day post-earnings move was +18.4%.
How much does CRDL stock move after earnings?
CRDL beat EPS estimates in 5 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 5.6% (up or down) in the day after earnings.
About Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc. is a clinical-stage life sciences firm dedicated to discovering and advancing anti-fibrotic and anti-inflammatory therapies for cardiovascular disease (CVD). Its leading candidate, CardiolRx, is currently undergoing a multi-national, randomized, double-blind, placebo-controlled Phase II/III study. This pivotal trial assesses CardiolRx's safety and effectiveness as a cardioprotective treatment to diminish cardiovascular and respiratory complications in hospitalized COVID-19 patients, while also investigating its potential for acute myocarditis. Furthermore, the company is developing a subcutaneous version of CardiolRx, aimed at addressing the cardiac fibrosis and inflammation linked to the onset and progression of heart failure. Cardiol Therapeutics Inc. was established in 2017 and operates from its headquarters in Oakville, Canada.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-13 | -0.09 | -0.04 | +55.56% | — | ✅ Beat | +18.42% | +28.95% | +31.25% | |
| 2026-08-12 | Q2 2026 | -0.09 | -0.04 | +60.00% | $0 | ✅ Beat | +12.50% | +28.95% | +31.25% |
| 2026-05-11 | Q1 2026 | -0.07 | -0.07 | +0.00% | $0 | ➖ Inline | +1.12% | -4.12% | -21.35% |
| 2026-03-31 | Q4 2025 | -0.09 | -0.05 | +44.44% | $0 | ✅ Beat | +3.70% | -4.44% | +2.22% |
| 2025-11-13 | Q3 2025 | -0.09 | -0.09 | +0.00% | $0 | ➖ Inline | +0.00% | -5.39% | +0.98% |
| 2025-08-14 | Q2 2025 | -0.10 | -0.07 | +28.00% | $0 | ✅ Beat | -2.24% | -12.69% | -19.40% |
| 2025-03-31 | Q4 2024 | -0.08 | -0.07 | +12.50% | $0 | ✅ Beat | -4.35% | -12.35% | +13.43% |
| 2024-11-14 | Q3 2024 | -0.09 | -0.13 | -44.44% | $0 | ❌ Miss | -2.15% | -15.05% | -28.49% |
Showing last 8 quarters.